Calcium-peroxide feed supplementation for finishing beef
University of Galway researchers have identified calcium peroxide as a promising anti-methanogenic feed additive for finishing beef cattle. Experimental studies demonstrate that supplementing cattle with calcium peroxide can reduce enteric methane emissions by 16% to 32% without compromising animal performance. The additive is compatible with standard feed pelleting processes, offering a potential pathway for farm-level implementation to help reduce the environmental impact of beef production.
Overview
Calcium peroxide is being researched as an anti-methanogenic feed supplement to reduce enteric methane emissions in beef cattle. By introducing a controlled release of oxygen into the rumen, this additive disrupts the environment required by methane-producing microbes. Research by the University of Galway indicates that this supplementation can significantly decrease daily methane production—by up to 32% depending on the dosage—without negatively impacting animal growth performance or health.
Technical specifications
The additive functions by modulating the rumen's oxidation-reduction potential. Key capabilities and findings include:
- Significant methane reduction ranging from 16% to 32% across various inclusion levels.
- Successful incorporation into both coarse rations and pelleted feed formats.
- Proven stability of the compound during the commercial pelleting process, which uses heat and pressure.
- Notable reductions in hydrogen production and shifts in rumen fermentation, specifically an increase in propionate concentration.
- No adverse impact on final body weight or average daily gain when administered in finishing beef systems.
Technology readiness level
The technology is currently at TRL 4-5. The efficacy and performance of calcium peroxide as a methane inhibitor have been demonstrated through controlled animal trials and validation in finishing beef systems. Research has confirmed the viability of pelleting the additive for easier farm-level application; however, further optimization regarding inclusion rates and delivery technology is ongoing.
About University of Galway
University of Galway is a comprehensive public research university on Ireland’s Atlantic coast, combining academic breadth with a strongly applied, partnership‑driven culture. Its integration with University Hospital Galway and the Saolta University Health Care Group gives companies access to clinicians, patients and trial infrastructure for timely translation. For industry, an Innovation Office and an Institute for Clinical Trials offer clear entry points for collaboration, IP and contracting, while proximity to Galway’s medtech hub supports rapid prototyping and validation. Research is supported by competitive national and European programmes, including Science Foundation Ireland and EU funding. A dedicated technology transfer office streamlines IP, licensing and startup formation.
delivered to your inbox.